Rakel Óttarsdóttir
Chief Tech/Sci/R&D Officer chez ICELANDAIR GROUP HF.
Profil
Rakel Óttarsdóttir is currently the Chief Digital Officer at Icelandair Group hf.
Prior to this, she worked as the Managing Director-Information Technology at Arion Banki HF from 2016 to 2019, and as Vice President at Össur hf.
In 2020, she became the Chief Information Officer at Alvotech hf, where she worked until 2022.
Ms. Óttarsdóttir holds an MBA from Duke University, which she received in 2002, and an undergraduate degree from the University of Iceland, which she received in 1997.
Postes actifs de Rakel Óttarsdóttir
Sociétés | Poste | Début |
---|---|---|
ICELANDAIR GROUP HF. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Rakel Óttarsdóttir
Sociétés | Poste | Fin |
---|---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Chief Tech/Sci/R&D Officer | 01/03/2022 |
ARION BANKI HF. | Chief Tech/Sci/R&D Officer | 20/09/2019 |
EMBLA MEDICAL HF. | Corporate Officer/Principal | - |
Formation de Rakel Óttarsdóttir
Duke University | Masters Business Admin |
University of Iceland | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
EMBLA MEDICAL HF. | Health Technology |
ICELANDAIR GROUP HF. | Transportation |
ARION BANKI HF. | Finance |
Entreprise privées | 1 |
---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |